Evidence map›Paper›PMID 18436877›Full record

ArticleStroke2008

Oxyhemoglobin-induced expression of R-type Ca2+ channels in cerebral arteries.

Timothy E Link, Kentaro Murakami, Micah Beem-Miller, Bruce I Tranmer, George C Wellman

Open access · bronzeAbstract read
In one paragraph

Article in Stroke, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. The L-type calcium channel CaV1.3: A potential target for cancer therapy.Journal of cellular and molecular medicine · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. The yin and yang of KMicrocirculation (New York, N.Y. : 1994) · 2018
    Review
  12. Article
  13. Review
  14. R-Type CaExperimental physiology · 2017
    Article
  15. Astrocyte Ca2+ Signaling Drives Inversion of Neurovascular Coupling after Subarachnoid Hemorrhage.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  16. Review
  17. Article
  18. Review
  19. Sulforaphane enhances the activity of the Nrf2-ARE pathway and attenuates inflammation in OxyHb-induced rat vascular smooth muscle cells.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Timothy E LinkDepartment of Pharmacology, University of Vermont College of Medicine, 86 Beaumont Ave, Burlington, VT 05405, USA.
Kentaro Murakami
Micah Beem-Miller
Bruce I Tranmer
George C Wellman
University of Vermont · US

Funding

Proteomics Core for Neuroscience P20 RR16435P20RR016435 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MARTIN-CARABALLO, MIGUEL · 2001 to 2010
$23.5M
Cerebral artery Ca2+ signaling &subarachnoid hemorrhageR01HL078983 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI WELLMAN, GEORGE C · 2005 to 2009
$2.0M
NCRR NIH HHS P20 RR016435NCRR NIH HHS P20 RR16435NHLBI NIH HHS R01 HL078983
6 · The paper itself

Abstract

background and purposeCerebral vasospasm after subarachnoid hemorrhage (SAH) is a major contributor to mortality and morbidity after aneurysm rupture. Recently, R-type voltage-dependent Ca(2+) channel (VDCC) expression has been associated with increased cerebral artery constriction in a rabbit model of SAH. The goal of the present study was to examine whether the blood component oxyhemoglobin (oxyHb) can mimic the ability of SAH to cause R-type VDCC expression in the cerebral vasculature.

methodsRabbit cerebral arteries were organ cultured in serum-free media for up to 5 days in the presence or absence of purified oxyHb (10 micromol/L). Diameter changes in response to diltiazem, (L-type VDCC antagonist) and SNX-482 (R-type VDCC antagonist) were recorded at day 1, 3, or 5 in arteries constricted by elevated extracellular potassium. RT-PCR was performed on RNA extracted from arteries cultured for 5 days (+/-oxyHb) to assess VDCC expression.

resultsAfter 5 days, oxyHb-treated arteries were less sensitive and partially resistant to diltiazem compared to similar arteries organ cultured in the absence of oxyHb. Further, SNX-482 dilated arteries organ cultured for 5 days in the presence, but not in the absence, of oxyHb. RT-PCR revealed that oxyHb treated arteries expressed R-type VDCCs (Ca(V) 2.3) in addition to L-type VDCCs (Ca(V) 1.2), whereas untreated arteries expressed only Ca(V) 1.2.

conclusionsThese results demonstrate that oxyhemoglobin exposure for 5 days induces the expression of Ca(V) 2.3 in cerebral arteries. We propose that oxyhemoglobin contributes to enhanced cerebral artery constriction after SAH via the emergence of R-type VDCCs.

Indexed as

Gene Expression RegulationAneurysmAnimalsCalcium Channel BlockersCalcium ChannelsCerebral ArteriesCulture Media, Serum-FreeDiltiazemEndothelium, VascularMaleMuscle, SmoothOxyhemoglobinsRabbitsSubarachnoid HemorrhageCalcium Channel BlockersCalcium ChannelsCulture Media, Serum-FreeDiltiazemOxyhemoglobins

Identifiers

PMID18436877
PMCPMC2581817
OpenAlexW2036649375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.